ADAMTS13 and COVID-19: A study showed imbalance between alteration of the VWF‐ADAMTS13 axis and elevated Von Willebrand factor antigen to ADAMTS13 activity ratio COVID‐19 patients that enhances risk of micro thrombosis and hypercoagulation [73].